SEIZERT CAPITAL PARTNERS, LLC – Eagle Pharmaceuticals, Inc. Transaction History
SEIZERT CAPITAL PARTNERS, LLC portfolio value:
$0
portfolio value
SEIZERT CAPITAL PARTNERS, LLC quarter portfolio value change:
-40.54%
quarter
Eagle Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -7.37K shares | -327K | $26.42 | 0 |
| Q2 2022 | share | 0.00% | 0 shares | -38K | $44.43 | 7.37K | |
| Q1 2022 | share | 0.00% | 0 shares | -10K | $49.49 | 7.37K | |
| Q4 2021 | share | Increase | 0.00% | 7.37K shares | 375K | $51.1 | 7.37K |
| Q3 2020 | share | Decrease | -100.00% | -19.84K shares | -952K | $42.48 | 0 |
| Q2 2020 | share | Decrease | -14.25% | -3.29K shares | -113K | $47.98 | 19.84K |
| Q1 2020 | share | Decrease | -8.06% | -2.03K shares | -448K | $46 | 23.14K |
| Q4 2019 | share | Increase | 0.00% | 25.17K shares | 1.51M | $60.08 | 25.17K |